Next Generation Cataract Surgery Study

NCT ID: NCT06071104

Last Updated: 2025-06-04

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

121 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-06

Study Completion Date

2024-06-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to obtain device-specific safety and performance clinical data to support marketability in Europe and to collect user preference data.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subjects will attend a screening visit (Day -60 to Day 0), a surgery visit (Day 0), and 3 post-surgical visits (Day 1, Week 1, Month 1) for an overall individual duration of up to 3 months. One eye (study eye) will be treated. This study will be conducted in the United States.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

UNITY VCS

Anterior segment ophthalmic surgery performed with UNITY VCS

Group Type EXPERIMENTAL

Anterior segment ophthalmic surgery

Intervention Type PROCEDURE

Cataract surgery during which the crystalline lens (often cloudy) is broken into small pieces and gently removed from the eye with suction (phacoemulsification)

UNITY VCS

Intervention Type DEVICE

UNITY Vitreoretinal Cataract System (VCS) with console, remote control, foot controller, UNITY Cataract FMS Pack, and UNITY Anterior Vitrectomy Kit

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Anterior segment ophthalmic surgery

Cataract surgery during which the crystalline lens (often cloudy) is broken into small pieces and gently removed from the eye with suction (phacoemulsification)

Intervention Type PROCEDURE

UNITY VCS

UNITY Vitreoretinal Cataract System (VCS) with console, remote control, foot controller, UNITY Cataract FMS Pack, and UNITY Anterior Vitrectomy Kit

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Able to understand and sign an IRB/IEC approved Informed Consent form.
* Willing and able to attend all scheduled visits as required by the protocol.
* Clinically documented diagnosis of age-related noncomplicated cataract.
* Eligible to undergo primary hydrophobic acrylic intraocular lens implantation into the capsular bag.

Exclusion Criteria

* Women of childbearing potential as defined in the protocol.
* Planned postoperative procedures during the course of the study in the operative eye.
* Previous intraocular or corneal surgery in the operative eye.
* Diagnosis of glaucoma or ocular hypertension (IOP \> 21 mmHg) in the operative eye.
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon Research

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Trial Lead, CRD Surgical

Role: STUDY_CHAIR

Alcon Research, LLC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gordon Schanzlin New Vision Institute, A TLC Laser Eye Center

San Diego, California, United States

Site Status

Miramar Eye Specialists Medical Group

Ventura, California, United States

Site Status

Wolfe Eye Clinic

West Des Moines, Iowa, United States

Site Status

Vance Thompson Vision

Sioux Falls, South Dakota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CTV678-E002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

AI-Enhanced Consent for Cataract Surgery
NCT06528509 NOT_YET_RECRUITING NA
IOP Changes Associated With SICS and Phako
NCT02642211 COMPLETED EARLY_PHASE1